November 6, 2017 by Chain Drug Review
Ari Bousbib, IMS Health, IQVIA, Quintiles, QuintilesIMS
Leading Headlines, Pharmacy, Supplier News, Technology
DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Global health care and pharmaceutical information specialist QuintilesIMS has changed its name to IQVIA. The IQVIA name became effective as of Nov. 6, the company said. Plans call for IQVIA equity shares to trade on the New York Stock Exchange under the ticker symbol “IQV” starting on
October 3, 2016 by Chain Drug Review
Ari Bousbib, health care information, IMS Health, Quintiles, QuintilesIMS, Tom Pike
Pharmacy, Supplier News, Technology
DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — IMS Health and Quintiles have combined to form a new global health care information and service provider, QuintilesIMS. The companies on Monday said they have completed their merger, an all-stock merger-of-equals transaction announced in May. The agreement united IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc.
May 3, 2016 by Chain Drug Review
Ari Bousbib, IMS Health, Quintiles, Tom Pike
Leading Headlines, Pharmacy, Supplier News, Technology
DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Health care and pharmaceutical information specialists IMS Health Holdings Inc. and Quintiles Transnational Holdings Inc. plan to merge. The companies said Tuesday that the deal is an all-stock merger of equals transaction, with the combined company to be named Quintiles IMS Holdings Inc. Plans call for the
November 23, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, Bernie Sanders, ColoradoCare, Health and Human Services, IMS Health, National Association of Chain Drug Stores, single-payer health care system, Sylvia Burwell, U.S. health care system, Walgreens Health Services
2015, Issue 11-23-2015, Issues, Opinion
More than five years after enactment of the Affordable Care Act, a measure designed to extend coverage to the uninsured and control expenditures, the turmoil in the U.S. health care system shows no signs of abating. Millions of Americans are still without health coverage, and health care costs continue to increase faster than the overall
November 18, 2015 by John Schultz and Chain Drug Review
global drug spending, global medicine use, global spend for pharmaceuticals, IMS Health, IMS Institute for Healthcare Informatics, Murray Aitken, prescription drug usage
Leading Headlines, Pharmacy, Supplier News
DANBURY, Conn. — More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31% a decade ago, as the “medicine use gap” between developed and pharmerging markets narrows, the IMS Institute for Healthcare Informatics projects. Global drug spending is
November 2, 2015 by Chain Drug Review
Harry Leider, IMS Health, medication adherence, Walgreens, Walgreens Health Services and Outcomes Research
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — New research by Walgreens finds that pharmacist interventions can play a key role in improving patients’ medication adherence and achieving related health care benefits. Walgreens said Monday that the study, titled “Improving Medication Adherence and Healthcare Outcomes in a Commercial Population Through a Retail Pharmacy Chain,” is one of the first to
September 14, 2015 by John Schultz and Chain Drug Review
2015 NACDS Total Store Expo, Bernie Greenberg Pharmacy Partnership Award, Darren Townzen, Harold W. Pratt Award, IMS Health, John Leubker, NACDS Foundation, National Association of Chain Drug Stores, Randy Edeker, Rite Aid, Robert Thompson, Sam's Club, Walmart
2015, Issue 09-14-2015, Issues, News
DENVER — Pharmacy veteran Robert Thompson received the Harold W. Pratt Award, considered pharmacy’s highest honor, from the National Association of Chain Drug Stores during a business program at the 2015 NACDS Total Store Expo. Thompson’s pharmacy career spans nearly four decades. Joining Rite Aid Corp. in 2004, he served in a variety of management
April 14, 2015 by Chain Drug Review and Chain Drug Review
IMS Health, IMS Institute for Healthcare Informatics, Use of Medicines in the U.S.
Featured Articles, Leading Headlines, Pharmacy, Retail News
PARSIPPANY, N.J. — Specialty medications helped drive a double-digit gain in total spending on medicines in the United States for 2014, as well as record volume in prescriptions dispensed, according to the IMS Institute for Healthcare Informatics, a unit of IMS Health. Last year, U.S. spending on medicines rose 10.3% on a real per capita
February 16, 2015 by Mark Tosh and Chain Drug Review
Doug Long, generic Copaxone, generic drug industry, generic drugs, generic Nexium, IMS Health, Red Oak Sourcing
Issue 02-16-2015, News, Pharmacy
NEW YORK — As the nation becomes more focused on affordable health care, generic drug companies are carving out a larger share of the U.S. market for prescription drugs. Perhaps the most significant sign of this continuing shift to generic drug utilization shows up in the market share data for actual prescriptions dispensed, brands compared